|
RVX TO HOST R&D UPDATE FEATURING KEY OPINION LEADERS IN CVD AND RENAL DISEASE
|
3
|
Resverlogix Corp.
|
Oct 04, 2016 09:25AM
|
|
RVX PRESENTS NEW DATA AND ESTABLISHES RENAL CLINICAL ADVISORY AT ERA-EDTA
|
2
|
Resverlogix Corp.
|
May 24, 2016 08:32PM
|
|
RVX Presenting at Roth today
|
3
|
Resverlogix Corp.
|
Mar 15, 2016 11:38AM
|
|
RVX in the next 7 weeks (revised)
|
2
|
Resverlogix Corp.
|
Aug 13, 2015 01:38PM
|
|
RVX in the next 7 weeks
|
6
|
Resverlogix Corp.
|
Aug 13, 2015 11:44AM
|
|
RVX in the next 5 weeks: ESC presentation 8/30
|
3
|
Resverlogix Corp.
|
Aug 26, 2015 07:26AM
|
|
RVX in the next 5 weeks
|
7
|
Resverlogix Corp.
|
Aug 12, 2016 10:47AM
|
|
RVX in Austria for ERA/EDTA and EAS
|
8
|
Resverlogix Corp.
|
May 17, 2016 05:14PM
|
|
RVX exposure
|
9
|
Resverlogix Corp.
|
Feb 12, 2016 12:27PM
|
|
RVX chasing BTI
|
1
|
Resverlogix Corp.
|
Sep 20, 2016 03:14PM
|
|
RVX Blog: ESC CONGRESS 2016 EPIGENETICS SYMPOSIUM: KOL VIDEO PRESENTATIONS
|
2
|
Resverlogix Corp.
|
Oct 05, 2016 04:11PM
|
|
RVX ANNOUNCES LEAD DRUG APABETALONE PUBLICATION AND BIO 2016 PRESENTATION
|
3
|
Resverlogix Corp.
|
Jun 02, 2016 08:33AM
|
|
RVX ANNOUNCES DOSING OF FIRST TWO PATIENTS IN EXPANDED RENAL AND ORPHAN PROGRAMS
|
3
|
Resverlogix Corp.
|
Jul 21, 2016 02:38PM
|
|
RVX Announces 2nd Positive Recommendation From DSMB
|
1
|
Resverlogix Corp.
|
Dec 05, 2016 12:21PM
|
|
RVX and Zenith presenting at Biotech Showcase Jan 11-13 and Zenith AGM Jan 7
|
3
|
Resverlogix Corp.
|
Dec 01, 2015 11:31AM
|
|
RVX abstract for IDF 2015 World Diabetes Congress
|
6
|
Resverlogix Corp.
|
Nov 30, 2015 11:39AM
|
|
RVX abstract for IDF 2015 World Diabetes Congress
|
7
|
Resverlogix Corp.
|
Nov 16, 2015 01:36PM
|
|
Roth coverage
|
4
|
Resverlogix Corp.
|
Oct 29, 2018 11:59AM
|
|
Roth Conference March 19th 11:00 AM Fireside Chat
|
4
|
Resverlogix Corp.
|
Mar 07, 2019 12:27PM
|
|
ROTH conference March 13-16
|
2
|
Resverlogix Corp.
|
Mar 10, 2016 01:23PM
|
